Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Effects of smoking on visual acuity of central serous chorioretinopathy patients.

Türkcü FM, Yüksel H, Sahin A, Cinar Y, Cingü K, Arı S, Sahin M, Altındağ S, Caça I.

Cutan Ocul Toxicol. 2014 Jun;33(2):115-9. doi: 10.3109/15569527.2013.810633. Epub 2013 Jul 10.

PMID:
23841829
2.

[Recurrent and chronic central serous chorioretinopathy. Retina thickness evaluation one month after intravitreal bevacizumab injection].

Gregori-Gisbert I, Aguirre-Balsalobre F, García-Sánchez J, León-Salvatierra G, Mengual-Verdú E, Hueso-Abancéns JR.

Arch Soc Esp Oftalmol. 2011 Dec;86(12):407-11. doi: 10.1016/j.oftal.2011.05.021. Epub 2011 Oct 11. Spanish.

PMID:
22117740
3.

Results of one-year follow-up examinations after intravitreal bevacizumab administration for chronic central serous chorioretinopathy.

Inoue M, Kadonosono K, Watanabe Y, Kobayashi S, Yamane S, Arakawa A.

Ophthalmologica. 2011;225(1):37-40. doi: 10.1159/000314709. Epub 2010 Aug 7.

PMID:
20693820
4.

Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy.

Behnia M, Khabazkhoob M, Aliakbari S, Abadi AE, Hashemi H, Pourvahidi P.

Retina. 2013 Feb;33(2):324-8. doi: 10.1097/IAE.0b013e3182670fa3.

PMID:
23314231
5.

Low luminance visual acuity in patients with central serous chorioretinopathy.

Fujita K, Shinoda K, Matsumoto CS, Imamura Y, Mizutani Y, Tanaka E, Mizota A, Oda K, Yuzawa M.

Clin Exp Optom. 2013 Jan;96(1):100-5. doi: 10.1111/j.1444-0938.2012.00796.x. Epub 2012 Sep 10.

6.

High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.

Ooto S, Hangai M, Sakamoto A, Tsujikawa A, Yamashiro K, Ojima Y, Yamada Y, Mukai H, Oshima S, Inoue T, Yoshimura N.

Ophthalmology. 2010 Sep;117(9):1800-9, 1809.e1-2. doi: 10.1016/j.ophtha.2010.01.042. Epub 2010 Jul 29.

PMID:
20673590
7.

Intravitreal bevacizumab injection for central serous chorioretinopathy.

Lim SJ, Roh MI, Kwon OW.

Retina. 2010 Jan;30(1):100-6. doi: 10.1097/IAE.0b013e3181bcf0b4.

PMID:
20010322
8.

Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy.

Lim JW, Kang SW, Kim YT, Chung SE, Lee SW.

Br J Ophthalmol. 2011 Apr;95(4):514-7. doi: 10.1136/bjo.2010.182121. Epub 2010 Jul 19.

PMID:
20644214
9.

Morphologic changes and visual outcomes in resolved central serous chorioretinopathy treated with ranibizumab.

Ozdemir O, Erol MK.

Cutan Ocul Toxicol. 2014 Jun;33(2):122-6. doi: 10.3109/15569527.2013.812104. Epub 2013 Jul 12.

PMID:
23848591
10.

Subthreshold Micropulse Laser (577 nm) Treatment in Chronic Central Serous Chorioretinopathy.

Scholz P, Ersoy L, Boon CJ, Fauser S.

Ophthalmologica. 2015;234(4):189-94. doi: 10.1159/000439600. Epub 2015 Sep 26.

PMID:
26406874
11.

Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study.

Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Bahcecioglu H.

Curr Eye Res. 2010 Feb;35(2):91-8. doi: 10.3109/02713680903428306.

PMID:
20136418
12.

[Photodynamic therapy in a patient with chronic central serous chorioretinopathy--a case report].

Pociej W, Karska-Basta I, Kolár L, Oleksy P, Romanowska-Dixon B.

Klin Oczna. 2014;116(1):28-31. Polish.

PMID:
25137918
13.

Multimodal imaging for the diagnosis of an atypical case of central serous chorioretinopathy.

Kahloun R, Chebbi A, Amor SB, Ksiaa I, Nacef L, Khairallah M.

Middle East Afr J Ophthalmol. 2014 Oct-Dec;21(4):354-7. doi: 10.4103/0974-9233.142279.

14.

Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series.

Salz DA, Pitcher JD 3rd, Hsu J, Regillo CD, Fineman MS, Elliott KS, Vander JF, Fischer DH, Spirn MJ.

Ophthalmic Surg Lasers Imaging Retina. 2015 Apr;46(4):439-44. doi: 10.3928/23258160-20150422-06.

PMID:
25970864
15.

Intravitreal bevacizumab in central serous chorioretinopathy.

Jamil AZ, Rahman FU, Iqbal K, Ansari HM, Iqbal W, Mirza KA.

J Coll Physicians Surg Pak. 2012 Jun;22(6):363-6. doi: 06.2012/JCPSP.363366.

PMID:
22630094
16.

Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study.

Golshahi A, Klingmüller D, Holz FG, Eter N.

Acta Ophthalmol. 2010 Aug;88(5):576-81. doi: 10.1111/j.1755-3768.2008.01467.x. Epub 2009 May 12.

17.

Clinical factors related to visual outcome in central serous chorioretinopathy.

Aggio FB, Roisman L, Melo GB, Lavinsky D, Cardillo JA, Farah ME.

Retina. 2010 Jul-Aug;30(7):1128-34. doi: 10.1097/IAE.0b013e3181cdf381.

PMID:
20616688
18.

Central serous chorioretinopathy.

Marcuson J, Riley T.

Optometry. 2008 May;79(5):241-51. doi: 10.1016/j.optm.2007.02.024.

PMID:
18436164
19.

Intravitreal bevacizumab injection for central serous chorioretinopathy.

Nowroozzadeh MH.

Retina. 2010 Sep;30(8):1322-3; author reply 1323. doi: 10.1097/IAE.0b013e3181e445b4. No abstract available.

PMID:
20827148
20.

Intravitreal bevacizumab injection for central serous chorioretinopathy.

Chhablani JK, Narayanan R.

Retina. 2010 Sep;30(8):1323-24; author reply 1324. doi: 10.1097/IAE.0b013e3181e46b09. No abstract available.

PMID:
20661171

Supplemental Content

Support Center